An effective chemotherapy‐free regimen of ponatinib plus venetoclax for relapsed/refractory  P hiladelphia chromosome‐positive acute lymphoblastic leukemia | Zendy

Short Nicholas J. | Zendy; Konopleva Marina | Zendy; Kadia Tapan | Zendy; Kebriaei Partow | Zendy; Daver Naval | Zendy; Huang Xuelin | Zendy; Masarova Lucia | Zendy; Cook Robin | Zendy; Jain Nitin | Zendy; Jabbour Elias | Zendy; Kantarjian Hagop | Zendy; Ravandi Farhad | Zendy

Premium

An effective chemotherapy‐free regimen of ponatinib plus venetoclax for relapsed/refractory P hiladelphia chromosome‐positive acute lymphoblastic leukemia

Author(s) -

Short Nicholas J.,

Konopleva Marina,

Kadia Tapan,

Kebriaei Partow,

Daver Naval,

Huang Xuelin,

Masarova Lucia,

Cook Robin,

Jain Nitin,

Jabbour Elias,

Kantarjian Hagop,

Ravandi Farhad

Publication year - 2021

Publication title -

american journal of hematology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.456

H-Index - 105

eISSN - 1096-8652

pISSN - 0361-8609

DOI - 10.1002/ajh.26175

Subject(s) - ponatinib , venetoclax , dasatinib , medicine , oncology , philadelphia chromosome , chemotherapy , acute lymphocytic leukemia , regimen , hematopoietic stem cell transplantation , myeloid leukemia , leukemia , immunology , cancer research , transplantation , imatinib , chronic lymphocytic leukemia , biology , lymphoblastic leukemia , chromosomal translocation , biochemistry , gene

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research